Abstract:Inflammation serves a key role in chronic obstructive pulmonary disease (COPD). However, changes in the immune profiles of patients with COPD remain unclear. The present prospective observational study aimed to determine the expression profiles of immune cells and inflammatory factors of patients with COPD and healthy controls, and to analyze the relationship between immune profiles and smoking history. A total of 140 subjects were enrolled in the present study between September 2018 and April 2019 at West China Hospital of Sichuan University (Chengdu, China). These included 87 patients with stable COPD and 24 patients with acute exacerbated COPD, as well as 29 healthy controls. Baseline characteristics were recorded during the screening period, and levels of immune cells were examined using flow cytometry. In addition, levels of inflammatory factors were measured using ELISAs. The results revealed increased expression of the CD64+/CD14+ mononuclear phagocyte system (MPS) and CD16+CD66+ neutrophils, and decreased expression of CD3+CD4+ T cells and CD3+ CD8+ T cells (all P<0.05) in the peripheral blood of patients with COPD and smokers relative to non‑smoking controls. In addition, significant differences were observed in protein levels of IL‑6, IL‑1β, TNF‑α, TGF‑α, IFN‑γ, IL‑8, IL‑17A and CRP among the three groups (all P<0.05). Furthermore, the IL‑17A, TNF and NF‑κB signaling pathways were found to serve a key role in the inflammatory network of COPD. Pearson's correlation analysis revealed a positive correlation between CD3+T lymphocyte counts and pulmonary function, and a negative correlation with smoking and exacerbations. Furthermore, neutrophils and MPS were negatively associated with pulmonary function, and IL‑8 was positively associated with cough. There was also a negative association between CRP and IL‑17A with pulmonary function but a positive correlation with symptoms and exacerbation. Club cell secretory protein was also negatively associated with emphysema parameters. In conclusion, the present findings revealed significant differences in profiles of immune factors among patients with COPD, smokers and non‑smoking controls and their association with clinical characteristics. The clinical trial registration number of the present study is: ChiCTR1800015700 (registered with http://www.chictr.org.cn/index.aspx, 2018/04/16).

The expression and imbalance of Th17 and Treg in peripheral blood of patients with stable chronic obstructive pulmonary disease

Imbalance of Peripheral Blood Th17 and Treg Responses in Patients with Chronic Obstructive Pulmonary Disease

Expression and significance of peripheral blood Th17 cells in patients with stable chronic obstructive pulmonary disease and smokers with normal lung function

The expression of Treg in peripheral blood and lung tissue of COPD

Imbalance Between Subpopulations of Regulatory T Cells in Copd

The expression and function of TH17 cells in chronic obstructive pulmonary disease

Change and Significance of Regulatory T Cell and Th17 Cell in Different Stage of Chronic Obstructive Pulmonary Disease

Role of Th17 cells, Treg cells, and Th17/Treg imbalance in immune homeostasis disorders in patients with chronic obstructive pulmonary disease

Increased IFN-γ-producing Th17/Th1 cells and their association with lung function and current smoking status in patients with chronic obstructive pulmonary disease

Imbalance of Th17/Treg Cells in Mice with Chronic Cigarette Smoke Exposure.

Peripheral Tc17 and Tc17/Interferon-γ Cells are Increased and Associated with Lung Function in Patients with Chronic Obstructive Pulmonary Disease.

Alteration of immune profiles is associated with pulmonary function and symptoms in patients with chronic obstructive pulmonary disease

Proportion of TH17 cells in peripheral blood of patients with chronic obstructive pulmonary disease and the effect of glucocorticoids

T-Helper 17 Cell/Regulatory T-Cell Imbalance in COPD Combined with T2DM Patients

Increased Expression of Interleukin-18 and Its Receptor in Peripheral Blood of Patients with Chronic Obstructive Pulmonary Disease.

An observation of Th1/Th2 unbalance in patients with chronic obstructive pulmonary disease

The Study of T Cells, IgA, IgG and Other Immune Function Situations in Patients with Chronic Obstructive Pulmonary Disease

Th1/Th17 Cytokine Profiles Are Associated With Disease Severity And Exacerbation Frequency In Copd Patients

To investigate the role of Th17 cell in lung tissue of tobacco smoke correlated COPD patients

Th17/Treg imbalance in COPD development: suppressors of cytokine signaling and signal transducers and activators of transcription proteins

Th1/Th2 in the Plasma from the Chronic Obstructive Pulmonary Disease Balance Disorder and Clinical Significance